The Lancet: Results of Phase 2b Trial of Novel TB Regimen PaMZ Show Potential to Shorten, Improve TB Treatment
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard
News
Global Phase 3 “STAND” Trial Launched to Test New Tuberculosis Drug Regimen PaMZ to Shorten, Improve Treatment
* STAND trial will take place in approximately 50 study sites in Africa, Asia, Caribbean, Eastern Europe, and Latin America
News
TB Alliance Advances Next-generation TB Drug Candidate into Clinical Testing
TB Alliance has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354.
News
Phase 2a Published Results Show the Potential of a New TB Regimen with Novel Drugs Bedaquiline and Pretomanid (PA-824)
A promising new tuberculosis (TB) drug regimen, which could improve the treatment of drug sensitive TB and multi-drug resistant (MDR-)
News
TB Alliance Announces Two New Members to Its Board of Directors: Dr. Mario Raviglione of WHO and Shalini Sharp of Ultragenyx
TB Alliance, an international not-for-profit organization with the mission of developing improved tuberculosis (TB) treatments, announced the appointment of Mario
News
Developing New Tuberculosis Drugs from Marine Natural Products: Joint research program between OPBIO and TB Alliance announced
OPBIO Factory Co., Ltd. (OPBIO) has signed a research agreement with the Global Alliance for TB Drug Development (TB Alliance).
News
Summary of TB Alliance & UNITAID symposium on the Pediatric TB Drug Market (full presentations available)
TB Alliance and UNITAID held a Satellite Symposium at the 45th Union World Conference on Lung Health on 31 October
News
TB Alliance Launches Phase 2B Clinical Trial of a Novel TB Drug Regimen that Could Cut Treatment Time by Half or More for a Majority of TB Patients
TB Alliance has launched a Phase 2B trial that will test the safety and effectiveness of a novel regimen with
News
Community Engagement Forum Brings Sites and Researchers Together to Improve Efforts
The 5th Annual Community Engagement (CE) Forum took place September 15-18, 2014 in Johannesburg, South Africa. This cross-site engagement opportunity
News
PA-824 has a New Generic Name: Pretomanid
TB Alliance announced today that pretomanid (pronounced: pree TOH mah nid) will be the generic, nonproprietary name for its novel